Supporting people in hospitals across South Australia through vital health and medical research and improved patient care.
Meet our passionate and dedicated team.
Meet our Board and Governance team.
THRF adopts extremely high transparency standards when reporting our financials.
Supports research into the detection, management & treatment of breast cancer.
Funding research into prostate cancer prevention, detection & treatment.
Improving heart health through advances in knowledge & research to beat heart disease.
Our aim is to reduce & eliminate the high incidence of chronic kidney disease and diabetes.
Supports health and wellbeing research & programs for veterans, emergency service personnel and their families.
Driving collaboration, innovation & research to develop best-practice arts, design & health programs.
Supporting world-class stroke research to improve prevention, diagnosis & acute treatment to cure stroke.
Providing donor stool to treat patients with bowel conditions and foster research into faecal transplant as a treatment.
Do you want to join our team? Check out current career opportunities here.
View some of the commonly asked questions about our organisation.
We are so grateful to those who donate their time and skills to support life-changing medical research. Find out more…
Get in touch with us here.
Ground-breaking research is underway boosting the body’s own immune system to fight the most common cancers affecting Australian families, including breast cancer.
The treatment is known as immunotherapy, and whilst it’s currently revolutionising blood cancer treatment, when it comes to solid cancers like breast cancer it’s not known to be as effective.
Thanks to your support, this is all about to change! In the first year of her PhD within the Breast Cancer Research Unit at the Basil Hetzel Institute for Translational Health Research (BHI), Namfon (Bee) Pantarat is developing a new immunotherapy treatment to target solid cancers such as breast cancer.
“Researchers believe we are at the threshold of a golden era for a therapy called ‘adoptive T Cell therapy’, a type of immunotherapy that involves isolating and reinfusing cancer fighting cells called ‘T cells’ back into a patient’s body,” Bee said.
“A recent clinical trial in terminally ill blood cancer patients, who only had months to live, showed extraordinary results with more than half of these patients experiencing complete remission by using this T cell therapy.
“However when trying to target solid tumours, which kill more people than blood cancers, the T cells are not as effective. We found that when we inject T cells into the bloodstream, most of them don’t travel to the tumour site but randomly go to other places in the body.”
Utilising the world-class medical equipment at the BHI, made possible thanks to you, Bee is developing a new therapy that will deliver these cancer fighting cells directly to the tumour.
“You can’t just inject these T cells straight into the tumour because they won’t last long in that environment. We are putting them in a gel and putting them right where the tumour is, within this gel there is food for them to keep them alive, so over time the cells will slowly drift out to fight cancer.”
Whilst currently using breast cancer as a basis for her research, Bee is hopeful her work will provide a viable therapy for other solid tumour including prostate cancer and brain tumours.
“I hope to offer an effective, complementary treatment for cancer patients, particularly those with tumours that are difficult to remove through surgery.
“There is a lot of work to be done to ensure our therapy will not just extent patient’s lives by a month or two, but ideally cure their cancer all together. That’s the hope!”
We look forward to providing you with an update on Bee’s potentially lifesaving treatment closer to the end of her PhD.
would you like to support breast cancer research?